Troy A. Ignelzi Karuna Therapeutics, Inc. (KRTX) insider trading activity

Troy A. Ignelzi is Chief Financial Officer of Karuna Therapeutics, Inc.. Currently has a direct ownership of 30,487 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Nov 10, 2020, when has been sold 118 shares (Common Stock) at a price of $103.48 per share, resulting in proceeds of $12,211. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.5K

0% 3M change

0% 12M change

Total Value Held $0

Troy A. Ignelzi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 10 2020	SELL Open market or private sale	$12,211 $103.48 p/Share	118 Reduced 2.31%	5,000 Common Stock
Nov 10 2020	BUY Exercise of conversion of derivative security	$1,086 $9.2 p/Share	118 Added 2.25%	5,118 Common Stock
Nov 09 2020	SELL Open market or private sale	$993,672 $106.64 p/Share	9,318 Reduced 65.08%	5,000 Common Stock
Nov 09 2020	BUY Exercise of conversion of derivative security	$85,726 $9.2 p/Share	9,318 Added 59.59%	6,318 Common Stock
Nov 06 2020	SELL Open market or private sale	$60,997 $108.15 p/Share	564 Reduced 10.14%	5,000 Common Stock
Nov 06 2020	BUY Exercise of conversion of derivative security	$5,189 $9.2 p/Share	564 Added 9.2%	5,564 Common Stock

Also insider at

CINC

CinCor Pharma, Inc. Healthcare

Director

CTNM

Contineum Therapeutics, Inc.

Director

RAPP

Rapport Therapeutics, Inc.

Chief Financial Officer

TAI

Troy A. Ignelzi

Chief Financial Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Karuna Therapeutics, Inc.

Track Activities on KRTX

Account